Publicaciones en colaboración con investigadores/as de Massachusetts General Hospital (53)

2023

  1. IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia

    Blood Advances

2022

  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    Blood, Vol. 140, Núm. 11, pp. 1200-1228

2021

  1. Minimal residual disease in Myeloma: Application for clinical care and new drug registration

    Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212

  2. Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19

    New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

  3. The T300A Crohn's disease risk polymorphism impairs function of the WD40 domain of ATG16L1

    Nature Communications, Vol. 7

2015

  1. A global reference for human genetic variation

    Nature, Vol. 526, Núm. 7571, pp. 68-74

2014

  1. Integrating sequence and array data to create an improved 1000 Genomes Project haplotype reference panel

    Nature Communications, Vol. 5

  2. Left ventricular end-diastolic pressure as an independent predictor of outcome during balloon aortic valvuloplasty

    Catheterization and Cardiovascular Interventions, Vol. 83, Núm. 5, pp. 782-788

  3. The echo score revisited: Impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty

    Circulation, Vol. 129, Núm. 8, pp. 886-895

  4. VAV3 mediates resistance to breast cancer endocrine therapy

    Breast Cancer Research, Vol. 16, Núm. 3

2013

  1. A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancers

    Oncogene, Vol. 32, Núm. 11, pp. 1452-1459

  2. Effect of elevated pulmonary vascular resistance on outcomes after percutaneous mitral valvuloplasty

    American Journal of Cardiology, Vol. 112, Núm. 4, pp. 580-584

  3. Long-term experience and outcomes with transcatheter closure of patent foramen ovale

    JACC: Cardiovascular Interventions, Vol. 6, Núm. 11, pp. 1176-1183

2012

  1. An integrated map of genetic variation from 1,092 human genomes

    Nature, Vol. 491, Núm. 7422, pp. 56-65

  2. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. Difference in outcome among women and men after percutaneous mitral valvuloplasty

    Catheterization and Cardiovascular Interventions, Vol. 77, Núm. 1, pp. 115-120

  2. Intravascular detection of the vulnerable plaque

    Circulation: Cardiovascular Imaging, Vol. 4, Núm. 2, pp. 169-178

2010

  1. Hyperglycemia on admission predicts larger infarct size in patients undergoing percutaneous coronary intervention for acute ST-segment elevation myocardial infarction

    Diabetes Research and Clinical Practice, Vol. 88, Núm. 1, pp. 97-102